IP Library Granted Patent US 7,790,040
Granted Patent B2
US 7,790,040 · App. 11/847,983 · Granted Sep 7, 2010

Continuous isocratic affinity chromatography

Assignee: Semba Biosciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,040
App. No.
11/847,983
Granted
Sep 7, 2010
Kind
B2
Abstract

The present invention provides devices and methods for micro-scale simulated moving bed chromatography (SMB) for continuous preparation of analytic quantities of highly pure fractions of target molecules. The present apparatus and method of the invention is adapted in a preferred embodiment to separations by affinity chromatography involving three discontinuous liquid flow loops. An alternative embodiment of affinity chromatography utilizes standard SMB operating under isocratic conditions.

Claims (32)

1. A method for isocratically purifying a target molecule having endogenous selective affinity for a ligand from a mixture of molecules in a feedstock using a simulated moving bed chromatography system, the system comprising a plurality of chromatography columns substantially filled with ligand-bound resin, inlets for feedstock and eluent, and outlets for extract and raffinate, the method comprising:

selecting a concentration of an affinity neutralizing agent sufficient to prevent static binding of the target molecule to the ligand-bound resin while selectively retarding passage of the target molecule through the ligand-bound resin in a mobile phase in contrast to molecules in the mixture not having such affinity;

adjusting the concentration of the affinity neutralizing agent in the feedstock and eluent to the selected concentration; and

processing the feedstock through the simulated moving bed chromatography system to recover a purified target molecule from the extract outlet.

2. The method of claim 1 , wherein the ligand is selected from the group consisting of chelated metal, glutathione, cellulose, streptavidin, calmodulin, Protein A, and Protein G.

3. The method of claim 1 , wherein the ligand is chelated Ni ++ .

4. The method of claim 1 , wherein the target molecule is a biomolecule.

5. The method of claim 4 , wherein the biomolecule is a protein.

6. The method of claim 5 , wherein the protein comprises a hexahistidyl tag.

7. The method of claim 1 , wherein the purity of the purified target molecule is at least 90%.

8. The method of claim 7 , further wherein the recovery of the purified target molecule is at least 70%.

9. The method of claim 7 , further wherein the recovery of the purified target molecule is at least 85%.

10. The method of claim 1 , wherein the purity of the purified target molecule is at least 95%.

11. The method of claim 1 , wherein the purity of the purified target molecule is at least 98%.

12. The method of claim 5 , wherein the protein has immune specificity.

13. A method for isocratically purifying a biomolecule having endogenous selective affinity for a ligand from a mixture of molecules in a feedstock using a simulated moving bed chromatography system, the system comprising a plurality of chromatography columns substantially filled with ligand-bound resin, inlets for feedstock and eluent, and outlets for extract and raffinate, the method comprising:

selecting a concentration of an affinity neutralizing agent sufficient to prevent static binding of the biomolecule to the ligand-bound resin while selectively retarding passage of the biomolecule through the ligand-bound resin in a mobile phase in contrast to molecules in the mixture not having such affinity;

adjusting the concentration of the affinity neutralizing agent in the feedstock and eluent to the selected concentration; and

processing the feedstock through the simulated moving bed chromatography system to recover a purified biomolecule from the extract outlet,

wherein the purity of the purified biomolecule is at least 90%.

14. The method of claim 13 , wherein the purity of the purified biomolecule is at least 95%.

15. The method of claim 13 , wherein the purity of the purified biomolecule is at least 98%.

16. The method of claim 13 , further wherein the recovery of the purified biomolecule is at least 70%.

17. The method of claim 13 , further wherein the recovery of the purified biomolecule is at least 85%.

18. The method of claim 13 , wherein the biomolecule is a protein.

19. The method of claim 18 , wherein the protein comprises a hexahistidyl tag.

20. A method for isocratically purifying a protein having endogenous selective affinity for a ligand from a mixture of molecules in a feedstock using a simulated moving bed chromatography system, the system comprising a plurality of chromatography columns substantially filled with ligand-bound resin, inlets for feedstock and eluent, and outlets for extract and raffinate, the method comprising:

selecting a concentration of an affinity neutralizing agent sufficient to prevent static binding of the protein to the ligand-bound resin while selectively retarding passage of the protein through the ligand-bound resin in a mobile phase in contrast to molecules in the mixture not having such affinity;

adjusting the concentration of the affinity neutralizing agent in the feedstock and eluent to the selected concentration; and

processing the feedstock through the simulated moving bed chromatography system to recover a purified protein from the extract outlet,

wherein the purity of the purified protein is at least 90% and the recovery of the purified protein is at least 70%.

21. The method of claim 20 , further wherein the protein comprises a hexahistidyl tag.

Assignments (3)
MERGER Recorded Jan 11, 2023
From: TOSOH BIOSCIENCE WISCONSIN, INC.
To: TOSOH BIOSCIENCE LLC
Reel/Frame 062346/0637 →
CHANGE OF NAME Recorded Jan 10, 2022
From: SEMBA BIOSCIENCES, INC.
To: TOSOH BIOSCIENCE WISCONSIN, INC.
Reel/Frame 058683/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2007
From: MIERENDORF, ROBERT CHARLES; GRABSKI, ANTHONY CHARLES; BAIER, JOERG WERNER; PAAREN, HERBERT EDMUND; WILKE, ANDREW; OROSKAR, ANIL RAJARAM
To: SEMBA BIOSCIENCES, INC.
Reel/Frame 020110/0204 →
Continuity (3)
Provisional Application 6091861700 · Mar 16, 2007
Provisional Application 6084129600 · Aug 30, 2006
Related Publication 20080053901A1 · Mar 6, 2008